NCT06557967View on ClinicalTrials.gov

Study on Prevalence and Impact of Brain Metastases on Survival in Lung Cancer by Line of Treatment

CompletedOBSERVATIONAL
Enrollment

22,517

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

June 28, 2024

Study Completion Date

September 30, 2024

Conditions
Non-small Cell Lung CancerLung CancerMetastatic CancerBrain and Central Nervous System Cancer
Interventions
OTHER

No drug

This is a non-interventional study and no study drug will be provided.

Trial Locations (1)

02138

ConcertAI Database, Cambridge

Sponsors

Lead Sponsor

Daiichi Sankyo
All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY

NCT06557967 - Study on Prevalence and Impact of Brain Metastases on Survival in Lung Cancer by Line of Treatment | Biotech Hunter | Biotech Hunter